-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Stick With Canopy Growth Stock Below $30
Canopy Growth is on the cusp of finally entering its hypergrowth phase, meaning it's time to get bullish on CGC stock.
Sundial: What to Make of This Marijuana Penny Stock
SNDL stock is surging on marijuana legalization hopes. However, here are the bigger issues that will really drive the share price.
Canopy Growth News: 5 Things for CGC Stock Investors to Know About the BioSteel-Philadelphia 76ers Deal
Shares of CGC stock are climbing higher on Wednesday after a company it holds a major stake in entered an agreement with an NBA franchise.
It’s Best to Leave Sundial Stock for the Gamblers
I get the appeal of the Sundial turnaround, but at this juncture, a bet on SNDL stock is a gamble, not an investment.
SNDL Stock: Why Cannabis Play Sundial Is Surging Monday
SNDL stock is surging Monday, likely thanks to news that U.S. lawmakers are turning back to landmark cannabis legislation.
With Pfizer Partnership, BioNTech Stock Should Push Higher
In light of a collaboration with a major drugmaker and a fast-track toward possible FDA approval, BNTX stock is practically irresistible.
Volatility May Continue, But CRISPR Stock Remains a Buy
Even after rebounding in recent weeks, consider now (or any pullback) prime time to enter a long-term position in CRISPR stock.
A Pro-Pot Biden Administration Isn’t Enough for Sundial Growers Stock
Favorable U.S. political developments and the underlying cannabis-infused products could lift Sundial Growers stock but it’s still a risky wager best left for gamblers.
MoneyLine Podcast: The Best Sectors for a Biden Administration
On this episode of MoneyLine, Matt McCall talks about what a Biden presidency would mean, as well as which sectors and stocks are set to blow.
MoneyLine Podcast: The Cannabis Sector Caught Fire after the Election & More
The cannabis sector was HOT after the election. What else is moving in the stock market? Quite a lot actually, the rally has slown down a bit, but there is still money to be made!
Repligen Stock: This Little-Known Biotech Posts Record Results
Repligen stock jumped 9% on the heels of the report to a new 52-week high of $203.90 today. And Louis Navellier sees a lot more upside for the company. Here's what potential RGEN stock investors should know.
Market Outlook: The Important Post-Election Statement
As we wait to find out who will take the White House, here are five key observations about the market’s early reaction, relating to the hypergrowth themes of cannabis, solar, infrastructure, sports gambling and healthcare.
Which Biotech Stocks Are a Buy on Earnings?
If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.
MoneyLine Podcast: Something Big Just Happened in the Healthcare Industry
On this episode of the MoneyLine podcast, Matt McCall covers bitcoin's breakout, guides you through the current market and shares investing ideas in genetic testing and more.
5 Keys to Find Small Stocks With 10X Potential
Matt McCall shares the five keys to look for in your hunt for small stocks that can return 10X your money. Plus: He gives an example of a stock that checks all the boxes. Take a look.
Cannabis Bulls Can Do Better Than Tilray Stock
TLRY stock has faded of late — and may continue to do so. There simply isn't a compelling reason to own the stock in a sector with better opportunities.
